CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 70 filers reported holding CARDIFF ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $71,154 | -5.4% | 51,190 | 0.0% | 0.00% | – |
| Q2 2023 | $75,249 | -10.9% | 51,190 | 0.0% | 0.00% | – |
| Q1 2023 | $84,464 | +17.9% | 51,190 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $71,666 | -9.3% | 51,190 | 0.0% | 0.00% | – |
| Q3 2022 | $79,000 | -30.1% | 51,190 | 0.0% | 0.00% | -100.0% |
| Q2 2022 | $113,000 | -11.0% | 51,190 | 0.0% | 0.00% | – |
| Q1 2022 | $127,000 | -58.8% | 51,190 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $308,000 | -11.7% | 51,190 | -2.2% | 0.00% | 0.0% |
| Q3 2021 | $349,000 | +2.6% | 52,349 | +2.3% | 0.00% | 0.0% |
| Q2 2021 | $340,000 | -35.8% | 51,190 | -10.5% | 0.00% | -50.0% |
| Q1 2021 | $530,000 | -76.4% | 57,220 | -54.1% | 0.00% | -75.0% |
| Q4 2020 | $2,245,000 | – | 124,788 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 120,600 | $265,000 | 0.37% |
| Artal Group S.A. | 750,000 | $1,650,000 | 0.09% |
| XTX Topco Ltd | 55,081 | $121,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 117,295 | $258,000 | 0.04% |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 23,800 | $52,000 | 0.03% |
| Atom Investors LP | 33,798 | $74,000 | 0.03% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 296,507 | $652,000 | 0.03% |
| Laurion Capital Management LP | 722,100 | $1,589,000 | 0.02% |
| MYDA Advisors LLC | 30,000 | $66,000 | 0.02% |
| Ergoteles LLC | 184,000 | $405,000 | 0.01% |